Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in

Cooper Companies Inc
F:CP60

Watchlist Manager
Cooper Companies Inc Logo
Cooper Companies Inc
F:CP60
Watchlist
Price: 53.62 EUR 0.56% Market Closed
Market Cap: €10.7B
Write Note Create Alert

Intrinsic Value

Is CP60 undervalued or overvalued?

See the intrinsic value estimate for Cooper Companies Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

CP60 Intrinsic Value
LOCKED
Unlock
Today vs. history

CP60 looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with CP60’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor CP60
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price €53.62
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CP60

Fundamental Analysis

What Cooper Companies Does

Health Care

Cooper Companies makes medical products in two main areas: contact lenses and women’s health. Through CooperVision, it sells soft contact lenses for nearsightedness, farsightedness, astigmatism, and presbyopia to eye doctors, optometrists, retailers, and patients. Through CooperSurgical, it sells tools and devices used by fertility clinics, hospitals, and other women’s health providers.

Headquarters
United States of America US
Employees
15 000
IPO date
Jan 21, 1983
Read the full company overview
View Company Overview

Cooper Companies has a narrow economic moat

No Moat Narrow Wide

Changing a successfully fitted contact lens takes extra clinical work and risks losing comfort or clear vision, which helps Cooper keep repeat customers. Approvals for specialized lenses also make it harder for new rivals to offer equivalent treatments without substantial testing and regulatory review.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Cooper Companies Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

COO Insider Trading
Buy and sell transactions by insiders

Continue CP60 Research

Summary
CP60 intrinsic value, competitors valuation, and company profile.
DCF Valuation
CP60 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CP60 stock valuation using valuation multiples.
Wall St Estimates
CP60 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CP60 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Cooper Companies Inc listings:
LSE • USD
0I3I
 BMV • MXN
COO
 NASDAQ • USD
COO
Discover More
What is the Intrinsic Value of one CP60 stock?

The intrinsic value for Cooper Companies Inc (CP60) under the Base Case is hidden EUR.

Is CP60 stock undervalued or overvalued?

Compared with the current market price of 53.62 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.